Home / Internal Medicine
Internal Medicine
| 4 min read
A new CRISPR center for kids, Trump threatens 200 percent tariffs on foreign-made drugs, the first malaria treatment for babies, and more led this week’s news. 
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
| 4 min read
Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.
| 10+ min read
Using artificial intelligence and machine learning, a team of researchers engineered an enzyme to degrade toxic PFAS molecules — and they’re only in high school.
| 3 min read
A blood test for organ rejection, another death related to gene therapy for Duchenne muscular dystrophy, a setback for AbbVie, and more led the news this week.
| 3 min read
Clinical trials rigorously test treatments to further scientific knowledge and benefit patients. Neither happens if the results are never published.
| 6 min read
Home-based healthcare is emerging as a scalable, cost-effective solution to rising systemic pressures, offering resilience in the face of economic, geopolitical, and operational uncertainty.
| 6 min read
A fragile and complex global supply chain leaves heparin vulnerable to disruption, prompting urgent calls for diversification, regulatory clarity, and investment in synthetic alternatives.
| 4 min read
The Bethesda Declaration, a new RSV antibody for kids, amylin’s promising weight loss results, and more were industry’s need-to-know stories this week.
| 5 min read
Promising small cell lung cancer results, COVID-19 vaccine confusion, billion-dollar deals, and more led the news this week.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 5 min read
From a bladder transplant to a blood test for Alzheimer's disease, there were a lot of firsts this week. Check them out here along with more industry news.
| 5 min read
From an executive order to lower drug prices to GLP-1 drug comparisons and a link between Parkinson’s disease and golf courses, it was a busy industry news week.
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
| 5 min read
What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.
| 4 min read
Landmark women’s health study loses funding, a promising antibody-drug conjugate for breast cancer, a schizophrenia drug setback, and more news from this week.
| 2 min read
Promising new data shows that Factor H (CPV-104) significantly reduces inflammation and retinal degeneration in an animal model of dry age-related macular degeneration
| 1 min read
Cyprumed GmbH and MSD have entered a non-exclusive agreement to develop oral peptide formulations using Cyprumed’s delivery technology.
| 5 min read
Stem cell therapy for Parkinson’s disease, discontinuation of Pfizer’s GLP-1 drug, a pig liver clinical trial, and more biotech and pharma news from this week.
Page 1 of 176 - 3519 Total Items
